Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Background:

• Prognosis for cardiogenic shock remains poor despite early revascularization and intra-aortic balloon pump counterpulsation.
• Percutaneous mechanical circulatory support (MCS) devices are increasingly used to improve outcomes.
• Limited high-quality evidence previously existed for these advanced MCS devices.

Purpose of the Study:

• To describe contemporary outcomes of cardiogenic shock.
• To explain the hemodynamics of cardiogenic shock and the effects of percutaneous MCS.
• To provide a framework for selecting and managing patients with percutaneous MCS devices.

Main Methods:

• Review of contemporary outcomes in cardiogenic shock.
• Analysis of hemodynamic principles and MCS device effects.
• Critical evaluation of existing data on various percutaneous MCS devices.

Main Results:

• Discussion of hemodynamic effects of percutaneous MCS devices.
• Critical review of data for and against intra-aortic balloon pump, Impella, TandemHeart, and ECMO.
• Identification of knowledge gaps in the use of these devices.

Conclusions:

• A multidisciplinary approach is essential for optimal patient-device matching.
• Expertise from interventional cardiology, heart failure, cardiac surgery, and anesthesiology is crucial.
• Further research is needed to address current gaps in understanding and management.